ArticleJournal of hematology & oncology2016

Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.

Annalisa Lonetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.